The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from PR Newswire

BD to Present at Investor Healthcare Conferences

Thursday, February 28, 2013

BD to Present at Investor Healthcare Conferences08:30 EST Thursday, February 28, 2013FRANKLIN LAKES, N.J., Feb. 28, 2013 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the following investor healthcare conferences in March 2013:Cowen and Company 33rd Annual Healthcare ConferenceMarch 4, 20131:30 p.m. ETRaymond James 34th Annual Institutional Investors ConferenceMarch 5, 20132:50 p.m. ETBarclays Global Healthcare ConferenceMarch 13, 201310:45 a.m. ETLive webcasts of BD's presentations can be accessed on the BD corporate website at www.bd.com/investors.  They will be available for replay for a period of seven days after each conference.  About BDBD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents.  The Company is dedicated to improving people's health throughout the world.  BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines.  BD's capabilities are instrumental in combating many of the world's most pressing diseases.  Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs nearly 30,000 associates in more than 50 countries throughout the world.  The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.  For more information, please visit www.bd.com.Contact:Monique N. Dolecki, Investor Relations ? 201-847-5378Colleen T. White, Corporate Communications ? 201-847-5369SOURCE BD (Becton, Dickinson and Company)